17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy: Difference between revisions

Jump to navigation Jump to search
 
(3 intermediate revisions by the same user not shown)
Line 6: Line 6:


==Surgical therapy==
==Surgical therapy==
*Patients with 17-beta hydroxysteroid dehydrogenase deficiency have [[moderate]] [[risk]] of [[germ cell tumor]]. These patients must be monitored closely, as the development of [[germ cell]] [[tumor]] requires the removal of the [[gonads]].<ref name="pmid2082839">{{cite journal| author=Melnik B, Hollmann J, Hofmann U, Yuh MS, Plewig G| title=Lipid composition of outer stratum corneum and nails in atopic and control subjects. | journal=Arch Dermatol Res | year= 1990 | volume= 282 | issue= 8 | pages= 549-51 | pmid=2082839 | doi=10.1007/BF00371952 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2082839  }} </ref>
*17-beta-hydroxysteroid dehydrogenase deficiency has a 28 % risk of [[germ cell tumor]] in [[disorder]] of [[sexual development]]. Consequently, close monitoring is warranted for an individual who is raised as a male rather than removing the [[gonads]] at the time of diagnosis.<ref name="urlThe Clinical and Molecular Heterogeneity of 17βHSD-3 Enzyme Deficiency - FullText - Hormone Research in Paediatrics 2010, Vol. 74, No. 4 - Karger Publishers">{{cite web |url=https://www.karger.com/Article/Fulltext/318004 |title=The Clinical and Molecular Heterogeneity of 17βHSD-3 Enzyme Deficiency - FullText - Hormone Research in Paediatrics 2010, Vol. 74, No. 4 - Karger Publishers |format= |work= |accessdate=}}</ref>
*[[Surgical]] [[treatment]] can also be used to treat [[anatomic]] changes due to the [[hormonal disorder]]. Patients with this disease may present with [[ambiguous]] or [[female genitalia]], despite most of them developing male [[gender identity]].  
*[[Surgical]] [[treatment]] can also be used to treat [[anatomic]] changes due to the [[hormonal]] [[disorder]]. Patients with this disease may present with [[ambiguous]] or [[female genitalia]], despite most of them developing male [[gender]] [[identity]].  
*Some studies have suggested that early surgical treatment may improve outcomes. [[Feminizing genitoplasty]] usually requires less [[surgical interventions]] than [[masculinizing genitoplasty]]. Outcomes vary greatly in both cases. Many patients may present with risk of [[neoplasia]] associated with the [[neovagina]], while regarding the masculinizing genitoplasty's results are heavily associated with the amount of [[erectile tissue]] and degree of [[hypospadias]].<ref name="pmid2082839">{{cite journal| author=Melnik B, Hollmann J, Hofmann U, Yuh MS, Plewig G| title=Lipid composition of outer stratum corneum and nails in atopic and control subjects. | journal=Arch Dermatol Res | year= 1990 | volume= 282 | issue= 8 | pages= 549-51 | pmid=2082839 | doi=10.1007/BF00371952 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2082839  }} </ref>
*Some studies have suggested that early surgical treatment may improve outcomes. [[Feminizing]] [[genitoplasty]] usually requires less [[surgical]] [[interventions]] than [[masculinizing]] [[genitoplasty]]. Outcomes vary greatly in both cases. Many patients may present with risk of [[neoplasia]] associated with the [[neovagina]], while regarding the masculinizing genitoplasty's results are heavily associated with the amount of [[erectile tissue]] and degree of [[hypospadias]].<ref name="pmid2082839">{{cite journal| author=Melnik B, Hollmann J, Hofmann U, Yuh MS, Plewig G| title=Lipid composition of outer stratum corneum and nails in atopic and control subjects. | journal=Arch Dermatol Res | year= 1990 | volume= 282 | issue= 8 | pages= 549-51 | pmid=2082839 | doi=10.1007/BF00371952 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2082839  }} </ref>


==References==
==References==

Latest revision as of 08:04, 20 October 2022

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy

CDC on 17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy

17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy in the news

Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy

Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency

Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]

Overview

Surgical therapy is guided by the risk of germ cell tumor development and to allow for proper gender assignment.

Surgical therapy

References

  1. "The Clinical and Molecular Heterogeneity of 17βHSD-3 Enzyme Deficiency - FullText - Hormone Research in Paediatrics 2010, Vol. 74, No. 4 - Karger Publishers".
  2. Melnik B, Hollmann J, Hofmann U, Yuh MS, Plewig G (1990). "Lipid composition of outer stratum corneum and nails in atopic and control subjects". Arch Dermatol Res. 282 (8): 549–51. doi:10.1007/BF00371952. PMID 2082839.

Template:WH Template:WS